Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis

Osteoarthritis and Cartilage

Volumn 16, Issue 5, 2008, Pages 566-571

  Chaganti, R K ^a   Kelman, A ^b,c   Lui, L ^d   Yao, W ^e   Javaid, M K ^f   Bauer, D ^g   Nevitt, M ^g   Lane, N E ^e  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GENENTECH INC   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h SOF)

Author keywords

Biomarkers; Cartilage

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN;

AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIP OSTEOARTHRITIS; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CROSS LINKING; RANDOM SAMPLE; RISK ASSESSMENT; RISK REDUCTION; TIME;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLLAGEN TYPE I; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; OSTEOARTHRITIS, HIP; PEPTIDES; PROGNOSIS;

EID: 42149127678     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.09.008     Document Type: Article

References (27)

1. Katz J.N. Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol 30 (2006) 145-153
2. Sharif M., Kirwan J.R., Elson C.J., Granell R., and Clarke S. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 50 (2004) 2479-2488
3. Conrozier T., Saxne T., Fan C.S., Mathieu P., Tron A.M., Heinegard D., et al. Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one-year prospective study. Ann Rheum Dis 57 (1998) 527-532
4. Bettica P., Cline G., Hart D., Meyer J., and Spector T. Evidence for increased bone resorption in patients with progressive knee osteoarthritis. Arthritis Rheum 46 12 (2002) 3178-3184
5. Bingham C.O., Buckland-Wright J.C., Garnero P., Cohen S.B., Dougados M., Adami S., et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee. Arthritis Rheum 54 (2006) 3494-3507
6. Kelman A., Lui L., Yao W., Krumme A., Nevitt M., and Lane N.E. Association of higher levels of serum cartilage oligomeric matrix protein and N-telopeptide crosslinks with the development of radiographic hip osteoarthritis in elderly women. Arthritis Rheum 54 1 (2006) 236-243
7. Lane N.E., Nevitt M.C., Hochberg M.C., Hung Y.Y., and Palermo L. Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. Arthritis Rheum 50 (2004) 1477-1486
8. Altman R.D., Hochberg M., Murphy Jr. W.A., Wolfe F., and Lesquene M. Atlas of radiographic features in osteoarthritis. Osteoarthritis Cartilage 3 Suppl A (1995) 3-70
9. Lane N.E., Nevitt M.C., Genant H.K., Hochberg M.C., Scott J.C., Pressman A.R., et al. Reliability of new indices of radiographic osteoarthritis of the hand and hip and lumbar disc degeneration. J Rheumatol 20 (1993) 1911-1918
10. Lesquene M. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24 (1997) 779-781
11. Lane N.E., Gore L.R., Cummings S.R., Hochberg M.C., Scott J.C., Pressman A.R., et al., for the Study of Osteoporotic Fractures Research Group. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Arthritis Rheum 42 (1999) 854-860
12. Nevitt M.C., Lane N.E., Scott J.C., Hochberg M.C., Pressman A.R., Genant H.K., et al. Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 38 (1995) 907-916
13. DiCesare P.E., Hauser N., Lehman D., Pasumarti D., and Paulsson M. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 354 (1994) 237-240
14. DiCesare P.A., Carlson C.S., Stollerman E.S., Chen P.A., Leslie M., and Perris R. Expression of cartilage oligomeric protein by human synovium. FEBS Lett 412 (1997) 249-252
15. Salminen H., Perala M., Lorenzo P., Saxne T., Heinegard D., Saamanen A.M., et al. Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthritis Rheum 43 (2000) 1742-1748
16. Urakami T., Manki A., Inoue T., Oda M., Tanaka H., and Morishima T. Clinical significance of decreased serum concentration of cartilage oligomeric matrix protein in systemic juvenile idiopathic arthritis. J Rheumatol 33 (2006) 996-1000
17. Bullough P.G. Pathology of osteoarthritis. In: Hochberg M.C., Silman A.J., Smolen J.S., Weinblatt M.E., and Weisman M.H. (Eds). Rheumatology. 3rd edn. (2003), Mosby, Philadelphia 1835-1845
18. Burr D.B. Increased biological activity of subchondral mineralized tissues underlies the progressive deterioration of articular cartilage in osteoarthrosis. J Rheumatol 32 6 (2005) 1156-1158
19. Jung Y.O., Do J.H., Kang H.J., Yoo S.A., Yoon C.H., Kim H.A., et al. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients. Clin Exp Rheumatol 24 (2006) 253-259
20. Bruyere O., Collette J., Kothari M., Zaim S., White D., Genant H., et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 65 (2006) 1050-1054
21. Sharif M., Granell R., Johansen J., Clarke S., Elson C., and Kirwan J. Serum cartilage matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee. Rheumatology (Oxford) 45 (2006) 522-526
22. Maeno Y., Inaba M., Okuno S., Yamakawa T., Ishimura E., and Nishizawa Y. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients. Clin Chem 51 12 (2005) 2312-2317
23. Fall P.M., Kennedy D., Smith J.A., Seibel M.J., and Raisz L.G. Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men. Osteoporos Int 11 (2000) 481-485
24. Morrow D., de Lemos J.A., Sabatine M.S., Wiviott S.D., Blazing M.A., Shui A., et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation 114 (2006) 281-288
25. Mundermann A., Dyrby C.O., Andriacchi T.P., and King K.B. Serum concentration of cartilage oligomeric matrix protein (COMP) is sensitive to physiological cyclic loading in healthy adults. Osteoarthritis Cartilage 13 (2005) 34-38
26. Neidhart M., Muller-Ladner U., Frey W., Bosserhoff A.K., Colombani P.C., Frey-Rindova P., et al. Increased serum levels of non-collageneous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage 8 (2000) 222-229
27. Andersson M.L., Thorstensson C.A., Roos E.M., Petersson I.F., Heinegard D., and Saxne T. Serum levels of cartilage oligomeric protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. BMC Musculoskelet Disord 7 (2006) 98-106